Ocera
Ocera is a biopharmaceutical company that focuses on the development and commercialization of ornithine phenylacetates.
Business Model:
Revenue: $609k
Employees: 11-50
Rankings
Industries / Tags:
Detailed Ocera Information
Ocera was acquired by
Mallinckrodt.
The acquisition happend on 2017-11-02.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 555 Twin Dolphin Dr
City: Redwood City
State: CA
Zip: 94065
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$20M
Raised Total:$97M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Ocera is a biopharmaceutical company that focuses on the development and commercialization of ornithine phenylacetates.
Contact Phone:
+16504750158
Contact Email:
Ocera went public on 4/4/2011 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/4/2011
IPO Valuation:
$95M
Ticker Symbol:
OCRX
IPO Price:
$4/share
Amount Raised:
$54M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
